The store will not work correctly when cookies are disabled.
N-[3,5-Dimethyl-4-(3-methyl-1H-indol-5-yloxy)-phenyl]-oxalamic acid ethyl ester
ID: ALA183057
PubChem CID: 10109471
Max Phase: Preclinical
Molecular Formula: C21H22N2O4
Molecular Weight: 366.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)C(=O)Nc1cc(C)c(Oc2ccc3[nH]cc(C)c3c2)c(C)c1
Standard InChI: InChI=1S/C21H22N2O4/c1-5-26-21(25)20(24)23-15-8-12(2)19(13(3)9-15)27-16-6-7-18-17(10-16)14(4)11-22-18/h6-11,22H,5H2,1-4H3,(H,23,24)
Standard InChI Key: RWEKLGLVVRRTRA-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
2.6792 -0.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2083 0.4708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8583 -0.6167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.0833 0.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3458 0.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8583 0.7208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9667 -0.7542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3917 -0.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2083 -0.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5042 0.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2292 -0.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0833 -0.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9333 0.8833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2292 0.4833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5042 -0.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3708 0.8833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6458 0.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6542 0.5000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4167 -1.5542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3708 -0.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6458 -0.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1042 -0.3000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.1208 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9208 -0.7625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4917 1.7208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8292 -0.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5292 -0.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 9 2 0
3 12 1 0
4 16 1 0
5 6 2 0
6 4 1 0
7 1 1 0
8 1 1 0
9 15 1 0
10 14 2 0
11 7 1 0
12 20 1 0
13 2 1 0
14 11 1 0
15 11 2 0
16 17 2 0
17 13 1 0
18 1 2 0
19 8 2 0
20 21 2 0
21 17 1 0
22 8 1 0
23 6 1 0
24 9 1 0
25 10 1 0
26 22 1 0
27 26 1 0
10 2 1 0
12 4 2 0
5 3 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 366.42 | Molecular Weight (Monoisotopic): 366.1580 | AlogP: 4.39 | #Rotatable Bonds: 4 |
Polar Surface Area: 80.42 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.96 | CX Basic pKa: ┄ | CX LogP: 5.05 | CX LogD: 5.05 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.53 | Np Likeness Score: -0.81 |
References
1. Haning H, Woltering M, Mueller U, Schmidt G, Schmeck C, Voehringer V, Kretschmer A, Pernerstorfer J.. (2005) Novel heterocyclic thyromimetics., 15 (7): [PMID:15780617] [10.1016/j.bmcl.2005.02.028] |